NASDAQ
Evome Medical Technologies Inc. (LNDZF) has a free cash flow growth of -43.50% as of Friday, May 29, 2026. This represents a 114.76% decrease compared to its 12-month average of 294.68%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.